http://www.unboundmedicine.com/medline/ebm/research/gemcitabineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19893461/full_citation/Features_of_gemcitabine_related_severe_pulmonary_toxicity:_patients_with_pancreatic_or_biliary_tract_cancer_Tamiya A, Endo M, Shukuya T, et al. 
Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer. [Journal Article]
Pancreas 2009 Oct; 38(7):838-40.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891026/full_citation/A_case_of_advanced_intrahepatic_cholangiocarcinoma_successfully_treated_with_chemosensitivity_test_guided_systemic_chemotherapy_Abe K, Wakatsuki T, Katsushima F, et al. 
A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy. [Journal Article]
World J Gastroenterol 2009 Nov 7; 15(41):5228-31.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19889615/full_citation/Premedication_with_20_mg_dexamethasone_effectively_prevents_relapse_of_extensive_skin_rash_associated_with_gemcitabine_monotherapy_Kanai M, Matsumoto S, Nishimura T, et al. 
Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19889608/full_citation/Combined_cetuximab_and_trastuzumab_are_superior_to_gemcitabine_in_the_treatment_of_human_pancreatic_carcinoma_xenografts_Larbouret C, Robert B, Bascoul-Mollevi C, et al. 
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887875/full_citation/Weekly_cetuximab_and_gemcitabine_plus_cisplatin_as_salvage_therapy_for_unresectable_non_small_cell_lung_cancer_Tai CJ, Hsu CH, Wang FJ, et al. 
Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer. [Letter]
Onkologie 2009 Nov; 32(11):685-6.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887545/full_citation/Small_molecule_inhibition_of_Wee1_kinase_by_MK_1775_selectively_sensitizes_p53_deficient_tumor_cells_to_DNA_damaging_agents_Hirai H, Iwasawa Y, Okada M, et al. 
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. [JOURNAL ARTICLE]
Mol Cancer Ther 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887465/full_citation/Gemcitabine_as_single_agent_in_pretreated_T_cell_lymphoma_patients:_evaluation_of_the_long_term_outcome_Zinzani PL, Venturini F, Stefoni V, et al. 
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19885591/full_citation/hSSTR2_expression_and_octreotide_treatment_reverses_multidrug_resistance_of_BxPC_3_human_pancreatic_cancer_cells_Sui C, Ma Q, Nan K, et al. 
hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells. [JOURNAL ARTICLE]
Oncol Rep 2009 Dec; 22(6):1391-1396.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884853/full_citation/Chemotherapy_Associated_Toxicity_in_a_Large_Cohort_of_Elderly_Patients_with_Non_small_Cell_Lung_Cancer_Hardy D, Cormier JN, Xing Y, et al. 
Chemotherapy-Associated Toxicity in a Large Cohort of Elderly Patients with Non-small Cell Lung Cancer. [JOURNAL ARTICLE]
J Thorac Oncol 2009 Oct 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884803/full_citation/A_Phase_I_Study_of_Flavopiridol_in_Combination_With_Gemcitabine_and_Irinotecan_in_Patients_With_Metastatic_Cancer_Fekrazad HM, Verschraegen CF, Royce M, et al. 
A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer. [JOURNAL ARTICLE]
Am J Clin Oncol 2009 Oct 30.
Abstract | Full Citation